Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes

Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes

New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant. Critical Path Institute’s Transplant Therapeutics Consortium received a qualification opinion for the iBOX Scoring System as a novel secondary efficacy endpoint for kidney transplant clinical trial...

Full description

Bibliographic Details
Main Authors: Amanda Klein, Alexandre Loupy, Mark Stegall, Ilkka Helanterä, Luke Kosinski, Eric Frey, Olivier Aubert, Gillian Divard, Kenneth Newell, Herwig-Ulf Meier-Kriesche, Roslyn Mannon, Thomas Dumortier, Varun Aggarwal, Jagdeep T. Podichetty, Inish O’Doherty, Ahmed Osama Gaber, William E. Fitzsimmons
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Transplant International
Subjects:
kidney transplant
iBox
transplant outcomes
organ transplant
transplant clinical trial
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11951/full

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2023.11951/full

Similar Items